Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
Preprint
Williams LR. et al, (2024)
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.
Journal article
Bijukchhe SM. et al, (2024), Vaccine
Evaluation of Acute and Convalescent Antibody Concentration Against Pneumococcal Capsular Polysaccharides for the Diagnosis of Pneumococcal Infection in Children with Community-Acquired Pneumonia
Journal article
Carter MJ. et al, (2024), Pediatric Infectious Disease Journal, 43, E67 - E70
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
Journal article
Ratcliffe H. et al, (2023), iScience, 26
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.
Journal article
Hill M. et al, (2023), BMJ Open, 13
Understanding COVID-19 testing behaviour in England through a sociodemographic lens
Preprint
Bajaj S. et al, (2023)
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults.
Journal article
Costa Clemens SA. et al, (2023), Hum Vaccin Immunother, 19
Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) - a protocol for two parallel, open-label, randomised controlled trials.
Journal article
Kelly S. et al, (2023), Trials, 24
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data
Journal article
Feng S. et al, (2023), eClinicalMedicine, 61
COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case-control study with SARS-CoV-2 genetic sequencing.
Journal article
Bijukchhe SM. et al, (2023), BMJ Open, 13
Assessment of vaccine herd protection in a cluster-randomised trial of Vi conjugate vaccine against typhoid fever: results of further analysis.
Journal article
Khanam F. et al, (2023), EClinicalMedicine, 58
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Journal article
Voysey M. et al, (2023), Clin Exp Immunol, 211, 280 - 287
A novel approach for estimating vaccine efficacy for infections with multiple disease outcomes: application to a COVID-19 vaccine trial
Preprint
Williams LR. et al, (2023)
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection.
Journal article
Mentzer AJ. et al, (2023), Nat Med, 29, 147 - 157
SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022.
Journal article
Koech A. et al, (2023), Front Public Health, 11
Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data.
Journal article
Liang Y. et al, (2022), Lancet Glob Health
A multistage mixed-methods evaluation protocol for the UKHSA testing response during the COVID-19 pandemic in England
Preprint
Naidoo R. et al, (2022)
Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study.
Journal article
Shrestha S. et al, (2022), Lancet Glob Health, 10, e1494 - e1504
Nasopharyngeal carriage of pneumococcus in children in England up to ten years after PCV13 introduction: persistence of serotypes 3 and 19A and emergence of 7C.
Journal article
Tiley KS. et al, (2022), J Infect Dis
Community seroprevalence of SARS-CoV-2 in children and adolescents in England, 2019-2021.
Journal article
Ratcliffe H. et al, (2022), Arch Dis Child